Showing 21 - 40 results of 81 for search '"NHL"', query time: 0.04s Refine Results
  1. 21

    The Feature of Distribution and Clonality of TCR γ/δ Subfamilies T Cells in Patients with B-Cell Non-Hodgkin Lymphoma by Liang Wang, Meng Xu, Chunyan Wang, Lihua Zhu, Junyan Hu, Shaohua Chen, Xiuli Wu, Bo Li, Yangqiu Li

    Published 2014-01-01
    “…To further characterize the γδ T-cell immune status in B-cell non-Hodgkin lymphoma (B-NHL), we investigated the distribution and clonality of TCR Vγ/Vδ repertoire in peripheral blood (PB), bone marrow (BM), and lymph node (LN) from patients with B-NHL. …”
    Get full text
    Article
  2. 22

    Obstructive Jaundice as an Initial Manifestation of Non-Hodgkin Lymphoma: Treatment Dilemma and High Mortality by Dhara Chaudhari, Sarah Khan, Atif Saleem, Tamarro Taylor, Chakradhar Reddy, Thomas Borthwick, Mark Young

    Published 2013-01-01
    “…Introduction. Non Hodgkin lymphoma (NHL) presenting with obstructive jaundice is a rare occurrence. …”
    Get full text
    Article
  3. 23

    Anaplastic, T-Cell, Non-Hodgkin's Lymphoma Presenting with Haematuria by C. Blick, S. Abdelhadi, D. Bailey, A. Muneer

    Published 2008-01-01
    “…Non-Hodgkin's lymphoma (NHL) represents about 3% of new cancer cases[1]. …”
    Get full text
    Article
  4. 24

    Monoclonal Antibodies for Non-Hodgkin's Lymphoma: State of the Art and Perspectives by Giulia Motta, Michele Cea, Eva Moran, Federico Carbone, Valeria Augusti, Franco Patrone, Alessio Nencioni

    Published 2010-01-01
    “…We will discuss these issues and present an overview of the most significant clinical studies with monoclonal antibodies for NHL treatment carried out to date.…”
    Get full text
    Article
  5. 25
  6. 26
  7. 27
  8. 28
  9. 29

    Initial versus Subsequent Injury and Illness and Temporal Trends Among Professional Hockey Players by Chelsea Martin, Allison Lieb, John Tokish, Ellen Shanely, Stefan Kluzek, Gary Collins, Garrett Bullock

    Published 2024-02-01
    “…# Background Research is limited investigating injuries/illness incidence among National Hockey League (NHL) players. This study sought to establish injury/illness incidence, initial versus subsequent injury risk among NHL players, and determine temporal trends of injury and illness incidence…”
    Get full text
    Article
  10. 30

    Variant Guillain-Barré Syndrome in a Patient with Non-Hodgkin’s Lymphoma by R. H. Bishay, J. Paton, V. Abraham

    Published 2015-01-01
    “…We report a 72-year-old female patient with diffuse large B cell non-Hodgkin’s lymphoma (NHL) with previous treatment with standard chemotherapy presenting as an acute, ascending, sensorimotor polyneuropathy. …”
    Get full text
    Article
  11. 31
  12. 32

    A Case of Chemotherapy-Refractory “THRLBCL like Transformation of NLPHL” Successfully Treated with Lenalidomide by Mamatha Siricilla, Lydia Irwin, Andres Ferber

    Published 2018-01-01
    “…It resembles non-Hodgkin lymphoma (NHL), by expressing classic B cell markers such as CD20 and CD79a however lacks definitive HL markers (such as CD15 and CD30). …”
    Get full text
    Article
  13. 33

    A Case of Primary Uterina Lymphoma Presenting with Bleeding, Pelvic Pain, and Dysmenorrhea by Lilian Yukari Miura, Miriam Anyury Daquin Maure, Monica Tessmann Zomer, Reitan Ribeiro, Teresa Cristina Santos Cavalcanti, William Kondo

    Published 2018-01-01
    “…Primary non-Hodgkin’s lymphoma (NHL) can arise from lymphatic cells located in solid organs (extranodal) and it accounts for 25 to 35% of all NHL. …”
    Get full text
    Article
  14. 34
  15. 35

    Multifocal Extranodal Involvement of Diffuse Large B-Cell Lymphoma by Devrim Cabuk, Y. Taha Gullu, Ilknur Basyigit, Ozgur Acikgoz, Kazım Uygun, Kursat Yildiz, Fusun Yildiz

    Published 2013-01-01
    “…A 68-year-old male with a prior diagnosis of colon non-Hodgkin lymphoma (NHL) was admitted to the hospital with a complaint of cough, sputum, and dyspnea. …”
    Get full text
    Article
  16. 36

    Association between B Cell Growth Factors and Primary Sjögren’s Syndrome-Related Autoantibodies in Patients with Non-Hodgkin’s Lymphoma by Zhenhua Xian, Dehua Fu, Shuang Liu, Yang Yao, Chun Gao

    Published 2019-01-01
    “…Our result provides a solid evidence to support using novel diagnostic panel to better stratify the NHL patients.…”
    Get full text
    Article
  17. 37

    B-cell non-Hodgkin's lymphoma in the patient with chronic hepatitis C and mixed cryoglobulinemia by V. S. Adonyeva, Ye. A. Kolodyazhnaya, A. B. Bochkarev

    Published 2015-03-01
    “…To describe clinical case of development B-cell non-Hodgkin's lymphoma (В-NHL) in the patient with chronic hepatitis C, to demonstrate potential of concurrent treatment of В-NHL and viral infection, regression of lymphoma on a background of antiviral therapy.Summary. …”
    Get full text
    Article
  18. 38

    Dual-targeting CAR T cells for B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma by Gustavo de Oliveira Canedo, Claire Roddie, Persis J. Amrolia

    Published 2025-02-01
    “…This review summarizes the state of the art with dual-targeting CAR T cells for B-cell ALL and B-NHL, the challenges encountered, and possible next steps to overcome them.…”
    Get full text
    Article
  19. 39

    Indolent B-Cell Lymphomas Associated with HCV Infection: Clinical and Virological Features and Role of Antiviral Therapy by Luca Arcaini, Michele Merli, Stefano Volpetti, Sara Rattotti, Manuel Gotti, Francesco Zaja

    Published 2012-01-01
    “…The association between hepatitis C virus (HCV) infection and B-cell non-Hodgkin’s lymphomas (NHL) has been demonstrated by epidemiological studies, in particular in highly endemic geographical areas such as Italy, Japan, and southern parts of United States. …”
    Get full text
    Article
  20. 40

    Diagnostic Value of Software-Based Image Fusion of Computed Tomography and F18-FDG PET Scans in Patients with Malignant Lymphoma by B. Henninger, D. Putzer, D. Kendler, C. Uprimny, I. Virgolini, E. Gunsilius, R. Bale

    Published 2012-01-01
    “…The purpose of this study was to evaluate the accuracy of 2-deoxy-2-[fluorine-18]fluoro-D-glucose (FDG) positron emission tomography (PET), computed tomography (CT), and software-based image fusion of both modalities in the imaging of non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD). Methods. 77 patients with NHL (𝑛=58) or HD (𝑛=19) underwent a FDG PET scan, a contrast-enhanced CT, and a subsequent digital image fusion during initial staging or followup. 109 examinations of each modality were evaluated and compared to each other. …”
    Get full text
    Article